Financial instruments (Tables)

6 Months Ended

Dec. 31, 2022

Fair Value Disclosures [Abstract]

Carrying values and estimated fair values of long-term debt

The carrying value of long-term debt, which excludes the impact of net unamortized debt issuance costs, and estimated fair value of long-term debt are as follows:

	December 31, 2022		June 30, 2022
Carrying value of long-term debt	$	12,437,722	$	10,145,077
Estimated fair value of long-term debt	11,746,087		9,709,407

Fair value derivative instruments reported in consolidated balance sheet

The location and fair value of derivative financial instruments reported in the Consolidated Balance Sheet are as follows:

	Balance Sheet Caption	December 31, 2022		June 30, 2022
Net investment hedges
Cross-currency swap contracts	Investments and other assets	$	22,615	$	21,444
Cross-currency swap contracts	Other liabilities	43		—
Other derivative contracts
Forward exchange contracts	Non-trade and notes receivable	16,494		20,976
Forward exchange contracts	Investments and other assets	48		—
Forward exchange contracts	Other accrued liabilities	43,611		5,651
Forward exchange contracts	Other liabilities	2,815		—
Deal-contingent forward contracts	Other accrued liabilities	—		1,015,426
Costless collar contracts	Non-trade and notes receivable	5,395		351
Costless collar contracts	Other accrued liabilities	2,123		1,578
Cross-currency swap contracts	Non-trade and notes receivable	17,327		—

Gain (losses) on derivative financial instruments recorded in consolidated statement if income

Gains (losses) on derivative financial instruments were recorded in the Consolidated Statement of Income as follows:

	Three Months Ended				Six Months Ended
	December 31,				December 31,
	2022		2021		2022		2021
Deal-contingent forward contracts	$	—	$	(149,382)	$	(389,992)	$	(149,382)
Forward exchange contracts	(13,439)		18,410		(14,803)		22,752
Costless collar contracts	(65)		(553)		5,324		(2,874)
Cross-currency swap contracts	(20,422)		—		(15,763)		—

Derivative and non-derivative financial instruments, gain (losses) recorded in accumulated other comprehensive (loss)

Gains (losses) on derivative and non-derivative financial instruments that were recorded in accumulated other comprehensive (loss) on the Consolidated Balance Sheet are as follows:

	Three Months Ended				Six Months Ended
	December 31,				December 31,
	2022		2021		2022		2021
Cross-currency swap contracts	$	(25,708)	$	16,945	$	1,111	$	29,317
Foreign currency denominated debt	(47,628)		10,785		(11,489)		25,649

Financial assets and liabilities measured at fair value on a recurring basis

A summary of financial assets and liabilities that were measured at fair value on a recurring basis at December 31, 2022 and June 30, 2022 are as follows:

			Quoted Prices		Significant Other		Significant
	Fair		In Active		Observable		Unobservable
	Value at		Markets		Inputs		Inputs
	December 31, 2022		(Level 1)		(Level 2)		(Level 3)
Assets:
Derivatives	$	61,879	$	—	$	61,879	$	—
Liabilities:
Derivatives	48,592		—		48,592		—

			Quoted Prices		Significant Other		Significant
	Fair		In Active		Observable		Unobservable
	Value at		Markets		Inputs		Inputs
	June 30, 2022		(Level 1)		(Level 2)		(Level 3)
Assets:
Equity securities	$	13,038	$	13,038	$	—	$	—
Derivatives	42,771		—		42,771		—
Liabilities:
Derivatives	1,022,655		—		1,022,655		—